Back to School: How biopharma can reboot drug development. Access exclusive analysis here
CBMI (Hopkinton, Mass.) announced that its further analysis of a pilot trial has shown statistical evidence of new dentin formation (p
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury